BCIQ Profiles

Company Profile ReportTarget Profile Report

Merck KGaA spins out cancer newco iOnctura with partner Cancer Research UK

Merck KGaA (Xetra:MRK) said that its Merck Ventures arm created immuno-oncology newco iOnctura S.A. (Geneva, Switzerland) with an undisclosed seed investment. The newco launched with two unnamed

Read the full 279 word article

How to gain access

Continue reading with a
two-week free trial.